FDA to cooperate in probe on pending drug applications

Published May 12, 2021, 3:51 PM

by Analou de Vera

The Food and Drug Administration (FDA) has vowed to cooperate with the investigation on the alleged delay in processing the drug applications of several pharmaceutical firms.

Food and Drug Administration (FDA)

“Ang FDA will cooperate fully with the authorities sa pag-investigate nito para makita po natin kung meron nga pong problema (The FDA will cooperate fully with the authorities in investigating this, so we can determine if there are problems),” said FDA Director-General Rolando Enrique Domingo in a radio interview on Wednesday, May 12.

Domingo said that his agency’s legal service office is currently looking at the matter.

“Yung aming legal service ngayon ay tumutulong na rin na hanapin itong mga applications na ito para malaman kung may pagkukulang man o may problema talaga at hindi naaaksyunan (Our legal service is now also helping in finding these applications to know if there are any shortcomings or problems, or inactions),” he said.

The Anti-Red Tape Authority (ARTA) on Tuesday, May 11, issued a show-cause order to FDA Center for Drug Regulation and Research Director Jesusa Cirunay due to the 600 pending drug applications filed by different pharmaceutical companies.